Comparable stake leader
Remi Gaston-Dreyfus
SEC ownership of Bionik Laboratories Corp.
Top holders, 13D/G large-stake signals, insider positions, and transaction flow tied to CIK 0001508381.
Disclosed value leader
Remi Gaston-Dreyfus
Comparable rows
0/5
Latest evidence
13 Jun 2023
- Parsed ownership sources
-
3/4/5
Source: Parsed SEC ownership filingsUse: Compare filing families carefully
- Largest SEC-reported holder
-
Remi Gaston-Dreyfus
Ranking: Comparable ownership first, then disclosed value
- Latest parsed ownership date
-
13 Jun 2023
Freshness: Most recent filing date in this holder set
- Issuer CIK
- 0001508381
- Issuer location
- Watertown, MA
Ownership snapshot
CIK-linked ownership evidence from parsed SEC filings.
1 signal
Issuer
Names, identifiers, and filing context for this profile.
2 identity fields
Ownership snapshot
Top shareholders of Bionik Laboratories Corp. (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Remi Gaston-Dreyfus
Disclosed value leader
Remi Gaston-Dreyfus
Comparable rows
0/5
Latest evidence
13 Jun 2023
3/4/5
Highest disclosed value: $2,987,403
5 rows are not safely comparable across share classes.
Quick read
Remi Gaston-Dreyfus has the largest disclosed position value at $2.99M.
0 of 5 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Remi Gaston-Dreyfus's linked filing trail.
Disclosed position value
Top 3
Remi Gaston-Dreyfus
$2.99M
Andre-Jacques Auberton-Herve
$729.1K
Charles Matine
$124.2K
Value bars compare disclosed positions; verify each figure against the linked filing evidence.
Detailed SEC evidence table Showing 1-5 of 5 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Remi Gaston-Dreyfus |
3/4/5
Director, 10%+ Owner
|
—
class O/S missing
|
$2,987,403
4,979,005 shares
|
— | 13 Jun 2023 |
| Andre-Jacques Auberton-Herve |
3/4/5
Director
|
—
mixed-class rows
|
$729,068
1,215,114 shares
mixed-class rows
|
— | 13 Jun 2023 |
| Charles Matine |
3/4/5
Director
|
—
class O/S missing
|
$124,191
206,985 shares
|
— | 09 Jun 2023 |
| Richard Paul Russo Jr. |
3/4/5
CEO and President
|
—
class O/S missing
|
—
60,000 shares
|
— | 06 Oct 2022 |
| Loren W. Wass |
3/4/5
Chief Commercialization Officer
|
—
class O/S missing
|
—
55,000 shares
|
— | 14 Oct 2021 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Forms 3/4/5 flow
Insider trading overview
Insider buy and sell flow is broadly balanced over the last 12 months. No Buy or Sell transactions have been reported since 21 Jul 2025.
Buys
$0
Insiders: 0
Sells
$0
Insiders: 0
Net
$0
Shares: 0
Window
Last 12 months
4 rolling buckets
Buy value
Sell value
Shares: 0
Shares: 0
| Window (months) | Buy shares | Sell shares | Buy value | Sell value | Net value |
|---|---|---|---|---|---|
| 0-3 | 0 | 0 | $0 | $0 | $0 |
| 3-6 | 0 | 0 | $0 | $0 | $0 |
| 6-9 | 0 | 0 | $0 | $0 | $0 |
| 9-12 | 0 | 0 | $0 | $0 | $0 |
Reporting owners
Insider holders from Forms 3/4/5
Showing 1-6 of 6 reporting-owner rows connected to Bionik Laboratories Corp.. Open a relationship link for the CIK-to-CIK filing trail.
Rows
6
Largest Forms 3/4/5 holder
Remi Gaston-Dreyfus
Net 12M change
$0
Latest report
13 Jun 2023
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Valuation | Report Date |
|---|---|---|---|---|---|---|
| Remi Gaston-Dreyfus | Director, 10%+ Owner | $2,987,403 | Mixed | 13 Jun 2023 | ||
| Andre-Jacques Auberton-Herve | Director | $729,068 | Mixed | 13 Jun 2023 | ||
| Charles Matine | Director | $124,191 | Mixed | 09 Jun 2023 | ||
| Richard Paul Russo Jr. | CEO and President | Mixed | 06 Oct 2022 | |||
| Daniel Gonsalves | Executive Vice President & CFO | Mixed | 06 Oct 2022 | |||
| Loren W. Wass | Chief Commercialization Officer | Mixed | 14 Oct 2021 |
Recent insider transactions for Bionik Laboratories Corp.
Showing up to 300 recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| No insider transactions were found in the last 12 months for this issuer. | ||||||||||
* marks a reported price that did not pass the local price check.